Literature DB >> 8821063

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I.

B Janetzky1, R God, G Bringmann, H Reichmann.   

Abstract

The neurotoxic agent MPP+ is an artificial substance producing a syndrome very similar to that of idiopathic Parkinson's disease. There are also naturally occuring neurotoxic substances under discussion like the group of isoquinoline and beta-carboline alkaloids. All these substances are more or less powerfull inhibitors of complex I of the mitochondrial oxidative phosphorylation. This study examined the effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a putative in vivo condensation product of chloralhydrate and tryptamine, on the oxidative phosphorylation system compared to MPP+. Similar to MPP+, TaClo inhibits only the electron transfer from complex I towards ubiquinone. Demonstrating a 10-times more effective inhibition than MPP+, complex I activity is fully inhibited by 800 microM TaClo in brain homogenates and submitochondrial particles. By extending the preincubation time from 5 to 30 min complex I is already inhibited by 400 microM TaClo. Other derivates of TaClo as N-methyl-TaClo demonstrate an even greater inhibitory effect on complex I and especially on complex II activities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821063

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Trichloroethylene and Parkinson's Disease: Risk Assessment.

Authors:  Mei Liu; Eun-Joo Shin; Duy-Khanh Dang; Chun-Hui Jin; Phil Ho Lee; Ji Hoon Jeong; Seok-Joo Park; Yong-Sun Kim; Bin Xing; Tao Xin; Guoying Bing; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2017-12-22       Impact factor: 5.590

4.  Traumatic brain injury and trichloroethylene exposure interact and produce functional, histological, and mitochondrial deficits.

Authors:  Andrew Sauerbeck; Randy Hunter; Guoying Bing; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2011-12-20       Impact factor: 5.330

5.  Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells.

Authors:  G Bringmann; R Brückner; R Mössner; D Feineis; A Heils; K P Lesch
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

6.  Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.

Authors:  A Storch; Y-I Hwang; G Bringmann; D Feineis; S Ott; R Brückner; J Schwarz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-01       Impact factor: 3.575

7.  1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.

Authors:  Rakesh Kumar Sharma; Eduardo Candelario-Jalil; Doris Feineis; Gerhard Bringmann; Bernd L Fiebich; Ravi Shankar Akundi
Journal:  Neurotox Res       Date:  2017-07-18       Impact factor: 3.911

8.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  P C Keane; M Kurzawa; P G Blain; C M Morris
Journal:  Parkinsons Dis       Date:  2011-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.